Baruchel S - Search Results

1

In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.

Zhang L, Smith KM, Chong AL, Stempak D, Yeger H, Marrano P, Thorner PS, Irwin MS, Kaplan DR, Baruchel S. Zhang L, et al. Among authors: baruchel s. Neoplasia. 2009 May;11(5):426-35. doi: 10.1593/neo.09166. Neoplasia. 2009. PMID: 19412427 Free PMC article.

2

Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.

Fouladi M, Stempak D, Gammon J, Klein J, Grant R, Greenberg ML, Koren G, Baruchel S. Fouladi M, et al. Among authors: baruchel s. Cancer. 2001 Aug 15;92(4):914-23. doi: 10.1002/1097-0142(20010815)92:4<914::aid-cncr1401>3.0.co;2-s. Cancer. 2001. PMID: 11550166 Clinical Trial.

3

Glutathione stability in whole blood: effects of various deproteinizing acids.

Stempak D, Dallas S, Klein J, Bendayan R, Koren G, Baruchel S. Stempak D, et al. Among authors: baruchel s. Ther Drug Monit. 2001 Oct;23(5):542-9. doi: 10.1097/00007691-200110000-00008. Ther Drug Monit. 2001. PMID: 11591901

4

Single-dose and steady-state pharmacokinetics of celecoxib in children.

Stempak D, Gammon J, Klein J, Koren G, Baruchel S. Stempak D, et al. Among authors: baruchel s. Clin Pharmacol Ther. 2002 Nov;72(5):490-7. doi: 10.1067/mcp.2002.129322. Clin Pharmacol Ther. 2002. PMID: 12426512 Clinical Trial.

5

Celecoxib in human milk: a case report.

Knoppert DC, Stempak D, Baruchel S, Koren G. Knoppert DC, et al. Among authors: baruchel s. Pharmacotherapy. 2003 Jan;23(1):97-100. doi: 10.1592/phco.23.1.97.31925. Pharmacotherapy. 2003. PMID: 12523466

6

In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy.

Das B, Yeger H, Baruchel H, Freedman MH, Koren G, Baruchel S. Das B, et al. Among authors: baruchel s, baruchel h. Eur J Cancer. 2003 Nov;39(17):2556-65. doi: 10.1016/j.ejca.2003.07.002. Eur J Cancer. 2003. PMID: 14602142

7

Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.

Cervi D, Klement G, Stempak D, Baruchel S, Koki A, Ben-David Y. Cervi D, et al. Among authors: baruchel s. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):712-9. Clin Cancer Res. 2005. PMID: 15701860

8

A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.

Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S. Das B, et al. Among authors: baruchel s. Cancer Res. 2005 Aug 15;65(16):7267-75. doi: 10.1158/0008-5472.CAN-04-4575. Cancer Res. 2005. PMID: 16103078

9

Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.

Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ. Lee A, et al. Among authors: baruchel s. Cancer Res. 2006 Apr 15;66(8):4378-84. doi: 10.1158/0008-5472.CAN-05-3810. Cancer Res. 2006. PMID: 16618763

10

Metronomic dosing of chemotherapy: applications in pediatric oncology.

Stempak D, Seely D, Baruchel S. Stempak D, et al. Among authors: baruchel s. Cancer Invest. 2006 Jun-Jul;24(4):432-43. doi: 10.1080/07357900600705599. Cancer Invest. 2006. PMID: 16777697 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters